Signals from the somatic compartment of ovarian follicles, such as from granulosa and cumulus cells, regulate oocyte developmental competence, which is defined as the capacity to support fertilization, pre-implantation phases of embryo development, and full-term development \[[@r1]\]. The somatic compartment is under the control of gonadotropins (follicle-stimulating hormone \[FSH\] and luteinizing hormone \[LH\]), which interact with the local growth factors and steroids during folliculogenesis \[[@r1]\].

During the antral stage of folliculogenesis, prior to the surge in gonadotrophin levels, FSH binds to the FSH receptor and modifies the follicular somatic cells that participate in the acquisition of oocyte competence, meiotic maturation and ovulation. The expression of LH and epidermal growth factor (EGF) receptors on follicular somatic cells is a well-characterized action exerted by FSH \[[@r2], [@r3]\]. Furthermore, FSH sustains gap junctional communication (GJC) among the follicular somatic cells as well as between the oocyte and cumulus cells \[[@r4]\], probably via cyclic adenosine monophosphate (cAMP)-protein kinase A (PKA) signaling \[[@r5]\]. GJC enables the passage of cAMP, cyclic guanosine monophosphate (cGMP), metabolites, exosomes, and potentially RNAs, into the oocytes, thereby playing a crucial role in the regulation of meiosis and oocyte competence \[[@r6],[@r7],[@r8]\]. During the ovulatory cascade, expression of the EGF-like peptides such as amphiregulin (AREG), epiregulin (EREG), and betacellulin (BTC) on mural granulosa cells is induced in rapid response to the FSH and LH surges; thereafter, the EGF-like peptides, cleaved and released from the cell surface by ectodomain sheddases such as ADAM metallopeptidase domain 17 (ADAM17), activate the EGFR on cumulus cells \[[@r9],[@r10],[@r11]\]. EGFR signaling stimulates expression of the extracellular matrix-related genes, such as hyaluronan synthase 2 (*HAS2*), tumor necrosis factor alpha-induced protein 6 (*TNFAIP6*), and prostaglandin-endoperoxide synthase 2 (*PTGS2*) that enables cumulus expansion essential for ovulation and oocyte capture by the infundibulum, in cooperation with signalling by the potent oocyte-secreted factors (OSFs), primarily bone morphogenetic protein 15 (BMP15), growth differentiation factor 9 (GDF9), and the BMP15/GDF9 heterodimer cumulin \[[@r12],[@r13],[@r14]\].

Oocytes gradually acquire developmental competence during folliculogenesis \[[@r15]\]. Hence, oocytes from small antral follicles have lower competence to reach the blastocyst stage compared to those from large follicles \[[@r16],[@r17],[@r18],[@r19]\]. In an experimental pig model, the cumulus-oocyte complexes (COCs) derived from small antral follicles possess less competence for cumulus expansion, in response to EGF or EGF-like peptides, partly because of immature EGFR signaling in cumulus cells \[[@r20],[@r21],[@r22]\]. This could possibly account for the low developmental competence of oocytes from small antral follicles. Hence, promotion of EGFR signaling in cumulus cells seems to be a key factor in the acquisition of oocyte developmental competence \[[@r21],[@r22],[@r23]\].

The proportion of bovine oocytes exhibiting developmental competence greatly increases in follicles \> 6 mm (medium-large antral) \[[@r24]\]. While some oocytes in 3-mm follicles (small antral) do possess a certain degree of developmental competence, they require additional "capacitation" or "pre-maturation" *in vivo* prior to the final maturation triggered by the surge in gonadotrophin levels to induce competence \[[@r25], [@r26]\]. Pre-maturation *in vivo* can be driven by advancing follicular growth with exogenous FSH priming; the oocytes derived from cows, treated with FSH prior to ovum pick up (OPU), have higher developmental competence than those derived from untreated cows \[[@r27],[@r28],[@r29]\]. Recently, we showed that FSH-priming *in vivo*, prior to oocyte retrieval, drastically modulates gene expression in the cumulus cells, particularly in relation to increased cell-cell communication, and enhances the responsiveness of cumulus cells to the EGF-like peptides, which are implicated in the acquisition of oocyte developmental competence \[[@r29]\].

Despite the fact that oocyte developmental competence is enhanced by FSH-priming, there are notable practical limitations in the process of FSH administration to animals/women: in cattle oocytes cannot be collected constantly, in comparison with conventional OPU without FSH-priming (non-stimulated or FSH-stimulated OPU sessions can be performed four times versus once in two weeks, respectively) \[[@r30]\], and the cost of embryo production is increased by the hormonal treatment. Moreover, depending on the environment and protocols \[[@r31]\], the herd invariably contains poor responders to FSH. Furthermore, when using slaughterhouse-derived ovaries, it is normal to collect ovaries from FSH-unprimed animals where mostly small antral follicles dominate. Therefore, it is highly desirable to develop an "*in vitro* pre-maturation" protocol (pre-IVM) that mimics as best as possible FSH administration prior to final oocyte maturation.

Along with other researchers, we have demonstrated that increasing COC cAMP levels, through pre-IVM with cAMP modulators, leads to greater oocyte developmental competence \[[@r32],[@r33],[@r34],[@r35],[@r36],[@r37],[@r38],[@r39]\]. In the present study, our aim was to analyze the participation of pre-IVM with cAMP modulators in the enhancement of EGFR signaling and cell-cell communication in cumulus cells, which are typically important for the acquisition of oocyte developmental competence \[[@r40]\]. Firstly, we examined the interactive effect of pre-IVM with established cAMP modulators, such as N6,2′-O-dibutyryladenosine 3′,5′-cyclic monophosphate (dbcAMP) and 3-isobutyl-1-methylxanthine (IBMX), and FSH/AREG on the *in vitro* development of bovine oocytes derived from small antral follicles (2- to 4-mm). Subsequently, we examined the effect of cAMP-modulated pre-IVM on FSH/AREG-induced cumulus expansion and its related genes such as *HAS2*, *TNFAIP6*, and *PTGS2* and EGF-like peptide-encoding gene expression such as *AREG*, *EREG* and *BTC*. Finally, the effects of cAMP modulators on *EGFR* expression and GJC were analyzed.

Materials and Methods {#s1}
=====================

Chemicals
---------

Unless specified, all chemicals were purchased from Sigma-Aldrich (St Louis, MO, US).

Animal care and use
-------------------

This study was approved by the Ethics Committee for the Care and Use of Experimental Animals at Tokyo University of Agriculture and Technology, Tokyo, Japan.

Oocyte collection
-----------------

Ovaries from Japanese Black or Japanese Black × Holstein breeds were collected from a local slaughter house, transported to the laboratory, washed, and stored in physiological saline. COCs were aspirated from small antral follicles (2--4 mm in diameter), using a 10-ml syringe equipped with a 19-gauge needle.

Pre-in vitro maturation
-----------------------

Depending on the experimental design ([Fig. 1](#fig_001){ref-type="fig"}Fig. 1.Schematic representation of the experimental design. COCs were cultured in IVM medium with/without 0.1 IU/ml FSH or 100 ng/ml AREG for 22 h (Standard IVM). As another experimental group, COCs were cultured in IVM medium with/without FSH and AREG after pre-IVM with/without 1 mM dbcAMP and 500 μM IBMX for 2 h (Pre-IVM).), immature COCs were cultured in HEPES-buffered TCM199 supplemented with 4 mg/mL of fatty-acid free bovine serum albumin (BSA) and 0.5 mM pyruvate (IVM medium), +/-- 1 mM dbcAMP and 500 µM IBMX, for 2 h during the pre-IVM period \[[@r21], [@r32], [@r39]\]. In a preliminary study, COCs were treated with either 1 mM dbcAMP and 500 µM IBMX or 100 μM forskolin (FSK) and 500 μM IBMX for 2 h, and then cultured in FSH-supplemented IVM medium for 22 h.

In vitro maturation
-------------------

The IVM medium was HEPES-buffered TCM 199 supplemented with 4 mg/ml of fatty-acid free BSA, 0.5 mM pyruvate, and no hormones (control), or 0.1 IU/ml FSH (Follistim; MSD, Tokyo, Japan) or 100 ng/ml recombinant human amphiregulin (AREG; R&D systems, Minneapolis, MN). These doses of FSH and AREG are based on previous studies \[[@r7], [@r29]\] demonstrating maximal benefit on oocyte developmental competence. Compacted COCs with \> 3 layers of cumulus cells and a homogeneous ooplasm were washed twice with the IVM medium and cultured in 100 μl IVM medium covered with paraffin oil (Paraffin Liquid; Nacalai Tesuque, Kyoto, Japan) in 35-mm Petri dishes at 38.5ºC in humidified atmosphere having 5% CO~2~ for 22 h.

COC expansion assay
-------------------

Cumulus expansion assay was performed as described earlier \[[@r41]\]. The expansion was scored at 22 h of IVM. Degree of cumulus expansion was scored between 0 to +4. A score of 0 indicated no detectable response, +1 indicated a minimal response (with cells in the peripheral two layers beginning to expand), +2 indicated an expansion extending inwards to several layers, +3 indicated an expansion of all cumulus layers (except the corona radiata cells), and +4 indicated an expansion of the entire cumulus including the corona radiate cells.

In vitro fertilization (IVF)
----------------------------

IVF was performed as reported previously \[[@r42]\]. Post IVM, the ejaculated sperm samples from Japanese black bulls were thawed and centrifuged in 3 ml of 90% Percoll solution (GE Healthcare, Uppsala, Sweden) at 750 × *g* for 10 min. After centrifugation, the pellet was re-suspended and centrifuged in 6 ml of sperm-washing solution (Brackett and Oliphant solution, BO) \[[@r43]\], supplemented with 10 mM hypotaurine and 4 U/ml heparin (Novo-Heparin Injection 1000; Aventis Pharma, Tokyo, Japan) at 550 × *g* for 5 min. The pellet was then re-suspended in sperm-washing solution and BO solution, supplemented with 20 mg/ml BSA to achieve a final concentration of 3 × 10^6^ sperm/ml. Droplets (100 µl each) of this suspension were aliquoted in 35-mm dishes under paraffin oil as fertilization droplets. COCs were washed twice in BO (supplemented with 10 mg/ml BSA) and cultured in the fertilization droplets for 6 h at 38.5ºC and 5% CO~2~ with saturated humidity.

In vitro culture (IVC)
----------------------

Charles Rosenkrans 1 medium with amino acids (CR1aa) supplemented with 5% calf serum was used as the IVC medium \[[@r44]\]. IVC of embryos was performed at 38.5ºC in 5% O~2~, 5% CO~2~, and 90% N~2~, with saturated humidity, for 7 days in 100 μl IVC medium droplets.

Real-time RT-PCR analysis
-------------------------

Real-time RT-PCR analysis was performed as previously described \[[@r29]\]. Cumulus cells were removed from immature COCs by pipetting with a grass pipette. Cumulus cells were lysed in 300 µl of RTL buffer containing 10 µl/ml of 2-mercaptoethanol and stored at --80°C. Total RNA was extracted from each sample using the RNeasy Micro Kit (Qiagen, CA). Genomic DNA was removed by recombinant RNase-free DNase I digestion (Qiagen). RNA was quantified using a NanoDrop spectrophotometer (Thermo Fisher Scientific, MA). Total RNA (200 ng), extracted from cumulus cells from 30 COCs, was reverse transcribed with random primers (Invitrogen, CA) using Super-Script III (Invitrogen). The real-time PCR analysis was performed on a StepOne^TM^ instrument (Applied Biosystems, Foster City, CA) in a 20-µl reaction volume containing 3 µl cDNA, 2.5 µl each of forward and reverse primers ([Table 1](#tbl_001){ref-type="table"}Table 1.Sequences of primers used for real-time RT-PCRGene nameGenBank accession numberPrimer sequences forward (F) and reverse (R)Amplicon size (bp)*RPL17*NM_001040516.1F: 5'- TGAGGCCCGCAGGTCTAAG-3'101R: 5'- CTTCCTCCTTGGACAGAGTCTTG-3'*HAS2*NM_17407.2F: 5'- GGATCTCCTTCCTCAGCAGTGT-3'106R: 5'- ATTCCCAGAGGTCCGCTAATG-3'*TNFAIP6*NM_001007813.2F: 5'- TGAAAGATGGGATGCATATTGC-3'101R: 5'- CATTTGGGAAGCCTGGAGATT-3'*PTGS2*NM_174445.2F: 5'- CTTAAACAAGAGCATCCAGAATGG-3'101R: 5'- GCTGTACGTAGTCTTCAATCACAATCT-3'*AREG*NM_001099092.1F: 5'-CTTTCGTCTCTGCCATGACCTT-3'100R: 5'-CGTTCTTCAGCGACACCTTCA-3'*EREG*XM_010797936.2F: 5'-ACTGCACAGCATTAGTTCAAACTGA-3'100R: 5'-TGTCCATGCAAACAGTAGCCATT-3'*BTC*NM_173896.2F: 5'-GCCCCAAGCAGTACAAGCAT-3'100R: 5'-GCCCCAGCATAGCCTTCATC-3'*ADAM17*XM_595713.8F: 5'-TGGGATGTGAAGATGTTGCTAGA-3'105R: 5'-ATCCAAGTGTTCCCATATCAAAATC-3'*EGFR*XM_592211.8F: 5'-ACCACCCATCCTGCCTGTATCAA-3'481R: 5'-TGCCCAAACGGACAACATTCTTCC-3'*FSHR*BT025383.1F: 5'-AGAGCAAGGTGACAGAGATTCC-3'91R:5'- ATGTAGTTTGGGCAGGTTGG-3'), 2 µl nuclease-free water, and 10 µl of SYBR Green PCR Master Mix (Applied Biosystems). PCRs were performed in duplicate. Universal thermal cycling parameters (initial step of 2 min at 50°C and 10 min at 95°C, followed by 40 cycles of 15 sec at 95°C and 60 sec at 60°C) were used. Melting curve analysis was carried out on the real-time cycler to check the specificity of the reaction. A standard curve was generated for the genes in every PCR run by using a serial 5-fold dilution of the amplified cDNA derived from cumulus cells. Final quantitative analysis of each gene was performed using the standard curve method and results were reported relative to the housekeeping gene of ribosomal protein L19 (*RPL19)*.

Gap junctional communication assay
----------------------------------

The degree of gap junctional communication in COCs was assessed using lucifer yellow (LY) dye microinjected into the ooplasm, as previously described \[[@r36]\]. After 0, 3, and 6 h of IVM, 3% LY in 5 mM lithium chloride was microinjected into the oocyte. The spread of dye into the surrounding cumulus cells was assessed under a confocal microscope within 15 min of injection. Individual COCs were scored as +2 when the dye was completely spread over the entire cumulus mass, +1 when the dye was transferred to limited number of cumulus cell layers (just beyond the corona radiata), and 0 when the dye was transferred to only the corona radiata cells or was not transferred to any cumulus cells at all. The average score of 10 COCs in each treatment group was calculated to generate the coupling index.

Statistical analyses
--------------------

All data were analyzed using analysis of variance (ANOVA) followed by Tukey-Kramer test with JMP software version 4.0.5 (SASS Institute, Cary, NC, USA). Prior to ANOVA, a Kolmogorov-Smirnov test and Bartlett's test were used to check normality and homogeneity of variance, respectively. All percentage data were arc-sine transformed prior to ANOVA. For all data, P \< 0.05 was considered statistically significant.

Results {#s2}
=======

Pre-IVM with dbcAMP and IBMX is effective for improving developmental competence of bovine oocytes
--------------------------------------------------------------------------------------------------

The effect of pre-IVM with different types of cAMP moderators (dbcAMP + IBMX versus FSK + IBMX) on oocyte developmental competence was examined ([Table 2](#tbl_002){ref-type="table"}Table 2.Comparison of pre-IVM with dbcAMP versus forskolin on oocyte developmental competenceIVM protocolNo. of cultured embryo\
(replicates)Percentage of embryos (mean ± SEM%)CleavageBlastocyst / CleavageTotal4 cells \<TotalExpanded stageStandard IVM \*91 (5)86.7 ± 2.567.9 ± 4.640.4 ± 2.2 ^b^29.0 ± 1.9 ^b^Pre-IVM with dbcAMP+IBMX \*\*96 (5)90.5 ± 2.170.6 ± 3.862.4 ± 4.9 ^a^52.1 ± 5.5 ^a^Pre-IVM with FSK+IBMX \*\*\*82 (5)80.7 ± 3.164.5 ± 6.153.2 ± 2.4 ^a^32.4 ± 3.4 ^ab^\* Cumulus oocyte complexes (COCs) were cultured in FSH-supplemented IVM medium for 22 h. \*\* COCs were treated with 1 mM dbcAMP and 500 μM IBMX for 2 h and then cultured in FSH-supplemented IVM medium for 22 h. \*\*\* COCs were treated with 100 μM forskolin (FSK) and 500 μM IBMX for 2 h and then cultured in FSH-supplemented IVM medium for 22 h. ^a,b^ Values are significantly different among IVM protocol (P \< 0.05).). Highest yield of total blastocysts and expanded blastocysts were observed using pre-IVM with dbcAMP + IBMX. Hence, this protocol was used as the pre-IVM condition in subsequent analyses.

Pre-IVM with cAMP modulators enhances the developmental competence of oocytes from COCs stimulated by FSH or AREG
-----------------------------------------------------------------------------------------------------------------

We examined the developmental competence of oocytes stimulated by FSH or AREG under conditions of standard IVM or pre-IVM with dbcAMP + IBMX ([Fig. 2](#fig_002){ref-type="fig"}Fig. 2.Effect of pre-IVM on developmental competence of oocytes from COCs unstimulated or stimulated by FSH or AREG. Prior to IVM, COCs were treated with or without dbcAMP and IBMX for 2 h (Pre-IVM). COCs were then cultured in IVM medium with/without FSH or AREG (Standard IVM). Effect of treatments on oocyte developmental competence were examined by evaluating the following embryonic developmental milestones: cleaved embryos (A), \> 4-cell embryos (B) at day 2 and blastocyst (C) and expanded blastocyst development (D) on day 7. Blastocyst and expanded blastocyst formation rates were expressed as a percentage of cleaved embryos. All values are represented as mean ± SEM of five replicate experiments. Bars with no common superscript letters are significantly different (P \< 0.05).). There was no significant difference in the rates of cleavage ([Fig. 2A](#fig_002){ref-type="fig"}) and formation of \> 4-cell embryos ([Fig. 2B](#fig_002){ref-type="fig"}) among the various treatment groups on day 2 (P \> 0.05). Regarding the rates of formation of total blastocysts ([Fig. 2C](#fig_002){ref-type="fig"}) and expanded blastocysts ([Fig. 2D](#fig_002){ref-type="fig"}), significant differences were observed between the control and FSH/AREG-stimulated groups under pre-IVM conditions but not under standard IVM. There was no significant difference between the FSH and AREG groups under conditions of standard IVM or pre-IVM conditions ([Fig. 2C and D](#fig_002){ref-type="fig"}). These results suggest that pre-treatment with cAMP modulators enhanced the effectiveness of FSH or AREG at improving oocyte developmental competence; achieving blastocyst rates of between 60--70%.

Treatment with cAMP modulators prior to oocyte maturation enhances the EGF-like peptide-cumulus expansion cascade
-----------------------------------------------------------------------------------------------------------------

Cumulus cell production of extracellular matrix molecules is a hallmark of terminal cumulus cell differentiation and is required for the ovulatory cascade. The expression of key associated genes is mediated by activation of EGFR signaling by the EGF-like peptides \[[@r45]\]. We measured morphological cumulus expansion and the expression of related genes such as *HAS2*, *TNFIP6*, and *PTGS2* ([Fig. 3](#fig_003){ref-type="fig"}Fig. 3.Cumulus expansion and related mRNA gene expression in FSH or AREG-stimulated/unstimulated cumulus cells under standard IVM conditions, with or without pre-IVM. Cumulus expansion index (A) of COCs was examined after 22 h of oocyte maturation. All values represent mean ± SEM of five replicate experiments. Expression of *HAS2* (B), *TNFIP6* (C) and *PTGS2* (D) in cumulus cells of COCs cultured for 6 h without (control) or with FSH or AREG in standard IVM, with or without pre-IVM. Gene expression was normalized to expression of the housekeeping gene *RPL19*. The control in the absence of both FSH and AREG was assigned a value of one and all other points are expressed relative to this point. Values represent mean ± SEM of five replicates. Bars with no common superscript letters indicate significant differences between treatments at P \< 0.05.), and the EGF-like peptide-encoding genes *AREG*, *EREG*, and *BTC* ([Fig. 4](#fig_004){ref-type="fig"}Fig. 4.EGF-like peptide and its sheddase related mRNA gene expression in FSH or AREG stimulated/unstimulated cumulus cells under standard IVM conditions, with or without pre-IVM. Expression of *AREG* (A), *EREG* (B), *BTC* (C) and *ADAM17* (D) in cumulus cells of COCs cultured for 6 h without (control) or with FSH or AREG in standard IVM, with or without cAMP-modulated pre-IVM. Gene expression was normalized to expression of the housekeeping gene *RPL19*. The control in the absence of both FSH and AREG was assigned a value of one, and all other points are expressed relative to this point. Values represent mean ± SEM of five replicates. Bars with no common superscript letters indicate significant differences between treatments at P \< 0.05.), in cumulus cells from COCs treated with/without FSH or AREG under conditions of standard IVM or cAMP-modulated pre-IVM. As expected, under standard IVM conditions, cumulus expansion was promoted by both FSH and AREG; however, the level of expansion in AREG-treated COCs was significantly lower than that in FSH-treated COCs ([Fig. 3A](#fig_003){ref-type="fig"}). On the other hand, under pre-IVM conditions, cumulus expansion was promoted by both FSH and AREG to the same level (P \> 0.05). Under conditions of both standard IVM and pre-IVM, FSH but not AREG stimulated *HAS2* ([Fig. 3B](#fig_003){ref-type="fig"}) and *PTGS2* expression ([Fig. 3D](#fig_003){ref-type="fig"}) (P \< 0.05). Likewise, *TNFAIP6* expression was stimulated by FSH, but not AREG, under standard IVM conditions (P \< 0.05; [Fig. 3C](#fig_003){ref-type="fig"}). FSH-stimulated *TNFAIP6* expression was further enhanced under pre-IVM conditions (P \< 0.05). Although stimulation of *TNFIP6* expression by AREG was somewhat induced following pre-IVM, the expression level was significantly lower than that with FSH stimulation ([Fig. 3C](#fig_003){ref-type="fig"}). Regarding the EGF-like peptide-encoding genes, the expression of *AREG* was promoted by FSH stimulation under pre-IVM but not under standard IVM (P \< 0.05); however, the expression was not stimulated by AREG in either pre-IVM and standard IVM (P \> 0.05; [Fig. 4A](#fig_004){ref-type="fig"}). Pre-IVM led to enhanced *EREG* expression in response to FSH or AREG, which did not occur under standard IVM conditions (P \< 0.05; [Fig. 4B](#fig_004){ref-type="fig"}). *BTC* was not stimulated by FSH or AREG under standard IVM or pre-IVM conditions ([Fig. 4C](#fig_004){ref-type="fig"}). *ADAM17*, encoding a sheddase for cleaving EGF-like peptides, was stimulated by FSH under pre-IVM but not under standard IVM (P \< 0.05), suggesting that pre-IVM with cAMP modulators enhances EGF-like peptide-cumulus expansion cascade following FSH or AREG stimulation.

Pre-IVM with dbcAMP and IBMX increases the expression of EGFR, but not FSHR
---------------------------------------------------------------------------

We examined the effect of the cAMP moderators; dbcAMP alone, IBMX alone, and dbcAMP + IBMX, on *EGFR* and *FSHR* expression by cumulus cells ([Fig. 5](#fig_005){ref-type="fig"}Fig. 5.Effect of cAMP-modulated pre-IVM on expression of *EGFR* and *FSHR* mRNA in cumulus cells. Expression of *EGFR* (A) and *FSHR* (B) in cumulus cells from COCs before pre-IVM (0 h) or after no treatment (control) or treatment with dbcAMP and/or IBMX for 2 h. Gene expression was normalized to expression of the housekeeping gene *RPL19*. The value at 0 h was set as one and all other points are expressed relative to this point. Values represent mean ± SEM of five replicates. Bars with no common superscript letters indicate significant differences between treatments at P \< 0.05.). Expression of *EGFR* ([Fig. 5A](#fig_005){ref-type="fig"}), but not *FSHR* ([Fig. 5B](#fig_005){ref-type="fig"}), after pre-IVM for 2 h was increased by the combination of dbcAMP and IBMX, but not by dbcAMP or IBMX alone (P \< 0.05), suggesting a possible regulation of *EGFR* expression by cAMP.

Pre-IVM with dbcAMP increases cell-to-cell communication
--------------------------------------------------------

Oocyte to cumulus cell and/or cumulus cell to cumulus cell gap junctional communication (GJC) was measured by assessing the transfer of LY dye from the oocyte to the surrounding cumulus vestment at 0, 3, and 6 h of *in vitro* maturation under standard IVM conditions or at 6 h of IVM following pre-IVM with/without dbcAMP or IBMX for 2 h ([Fig. 6](#fig_006){ref-type="fig"}Fig. 6.Regulation of oocyte-cumulus cells/cumulus cells-cumulus cells gap-junctional communication in COCs with standard IVM or pre-IVM conditions. LY diffusion of COCs cultured in IVM medium (Standard IVM) or in IVM medium after pre-IVM without (control) or with dbcAMP and/or IBMX for 2 h (Pre-IVM) was examined at 0, 3, and 6 h of *in vitro* oocyte maturation, respectively. No ligand was included in the IVM medium. Values represent mean ± SEM of five replicates. Points with different letters within a time-point indicate significant differences between treatments at P \< 0.05.). In general, pre-IVM with dbcAMP notably increased oocyte-cumulus cell GJC for the following 6 hours of IVM. At 0 h of IVM, the coupling index was increased by pre-IVM with dbcAMP alone or dbcAMP + IBMX, compared to that of standard IVM or pre-IVM without cAMP moderators (P \< 0.05). Similar findings were observed at 3 and 6 h. However, the coupling index of COCs treated with dbcAMP + IBMX was significantly higher than that of COCs treated with dbcAMP alone at 6 h of IVM. These results suggest that combined treatment with dbcAMP and IBMX prior to IVM can not only increase but also sustain GJC.

EGFR signaling triggered by pre-IVM with cAMP modulators participates in oocyte developmental competence
--------------------------------------------------------------------------------------------------------

To investigate whether the cAMP-modulated pre-IVM improvements in oocyte competence occur independent of EGFR or are a function of EGFR signaling, we examined the effect of AG1478, a well-known inhibitor of EGFR tyrosine kinase, on oocyte developmental competence. AG significantly decreased the rate of formation of \> 4 cell embryos ([Fig. 7B](#fig_007){ref-type="fig"}Fig. 7.Effect of EGFR signaling inhibition on developmental competence of oocytes matured following cAMP-modulated pre-IVM. COCs were treated with dbcAMP and IBMX for 2 h and then cultured in IVM medium supplemented with FSH or AREG, either in the absence (--AG) or presence of 10 μM of the EGFR tyrosine kinase inhibitor, AG1478 (+AG). Developmental competence was examined by measuring embryo development at the following time points: cleaved embryos (A), \> 4-cell embryos (B) at day 2 and embryos developed to the blastocyst (C) and expanded blastocyst stages (D) at day 7. Blastocyst and expanded blastocyst formation rates are expressed as a percentage of cleaved embryos. Values represent means ± SEM of five replicates. Bars with no common superscript letters indicate significant differences at P \< 0.05.) but not of cleavage ([Fig. 7A](#fig_007){ref-type="fig"}) in FSH- or AREG-stimulated oocytes. Under conditions of pre-IVM, FSH or AREG generated high blastocyst (71% and 66%, respectively) and expanded blastocyst rates; however, the additive benefit of FSH or AREG was ablated by AG treatment (P \> 0.05; [Fig. 7C and D](#fig_007){ref-type="fig"}). These results suggest that the improved oocyte developmental competence by pre-IVM in FSH- or AREG-stimulated oocytes is likely to result from the effects of pre-IVM with cAMP modulators on EGFR signaling.

Discussion {#s3}
==========

Differentiation and development of follicular somatic cells by FSH prior to final oocyte maturation is required for acquisition of oocyte developmental competence \[[@r3], [@r29]\]. However, to produce bovine or human IVM embryos*,* oocytes are usually derived from small antral follicles of FSH-unprimed donors (bovine) or following minimal FSH-stimulation (human). Oocytes from such small antral follicles have low developmental competence for many reasons, not least because of insufficient EGFR signaling in cumulus cells \[[@r20],[@r21],[@r22], [@r29], [@r46]\]. Here, we show that pre-maturation *in vitro* with cAMP modulators enhanced COC gap junctional communication and EGFR signaling stimulated by FSH or AREG in developing COCs from small antral follicles. This culminated in enhanced developmental competence of bovine oocytes and notable blastocyst yields of \~70%.

As observed in previous studies (reviewed; \[[@r40]\]), upregulation of COC cAMP levels prior to IVM seems to be effective in improving oocyte competence, as this has been shown to significantly improve the subsequent development of bovine \[[@r32], [@r34], [@r36], [@r37]\], porcine \[[@r21], [@r39]\], murine \[[@r32], [@r33], [@r38]\], ovine \[[@r35]\], and human IVM oocytes \[[@r47]\]. Consistent with this body of literature, in the current study pre-IVM for 2 h with cAMP modulators increased the developmental competence of bovine oocytes from small antral follicles. The optimal cAMP modulators for pre-IVM are currently unknown. dbcAMP was the original agent used \[[@r39]\] and is now widely used in porcine IVM protocols (reviewed; \[[@r40]\]). More recently COCs have been treated in pre-IVM with forskolin and IBMX, and this protocol has proven effective in several animal species including bovine, ovine, murine, and in humans. In the present study, we investigated the effect of pre-IVM on subsequent embryo development using the dbcAMP and IBMX and found this pre-IVM protocol effective at increasing blastocyst yield. We used this protocol as we found blastocyst yield to be higher with the dbcAMP + IBMX protocol than with the forskolin + IBMX protocol. Although the optimal pre-IVM duration and modulator concentration have been evaluated, it may be necessary, for each animal species, to optimize the type of cAMP modulator used for pre-IVM as well, as this is likely to affect oocyte developmental competence.

Previously, we reported that establishing functional EGFR signaling prior to the final ovulation cascade via EGF-like peptides is involved in acquisition of oocyte developmental competence, and that the FSH secondary messenger cAMP, in conjunction with the oocyte-secreted factors, are involved in the acquisition of functional EGFR signaling \[[@r21],[@r22],[@r23]\]. Furthermore, we recently showed that FSH-priming prior to OPU enhanced the responsiveness of cumulus cells to EGF-like peptides in a bovine model \[[@r29]\]. Other reports also demonstrated that FSH is required for fully functional EGFR signaling \[[@r3]\]. Richani *et al*. showed that pre-IVM with cAMP modulators significantly increases EGF-like peptide expression following FSH or EGF-like peptide stimulation compared to the standard IVM protocol \[[@r38]\]. However, in bovine small antral follicles, it was not clear whether pre-IVM with cAMP modulators is involved in enhancement of the EGF-like peptide-EGFR signaling axis in cumulus cells. In this study, pre-IVM with cAMP modulators enhanced FSH- or AREG-stimulated cumulus cell EGFR signaling, which was bolstered by an increase in expression of the extracellular matrix-related genes *HAS2*, *TNFIP6* and *PTGS2,* which are established down-stream molecules of EGFR signaling in mice \[[@r45]\]. This would be linked to increased expression of not only EGF-like peptides and sheddases, but also of EGFR encoding genes. In stimulated mice, the expression of *EGFR* at the end of pre-IVM was not affected by treatment with forskolin + IBMX \[[@r38]\]. This inconsistency may be due to differences in the animal species, the developmental stage of COCs examined, or the type of cAMP modulators used in this study. Although the relationship between FSH and *EGFR* expression has been demonstrated using *Fshb* (--/--) mice \[[@r3]\], further studies will be required to clarifying the relationship between cAMP signaling and *EGFR* expression.

Mechanisms accounting for the increased oocyte developmental competence resulting from pre-IVM with cAMP modulators may include, among others, increased and prolonged cell-to-cell gap junctional communication and enhanced EGFR signaling \[[@r40]\]. Cumulus cell-oocyte gap junctional communication is abruptly terminated during standard IVM, but can be readily prolonged by pre-IVM with elevated cAMP \[[@r34], [@r48], [@r49]\]. Premature gap junction closure during standard IVM leads to rapid chromatin condensation and cessation of oocyte RNA transcription; maintenance of this communication using PDE inhibitors, however, can positively alter chromatin remodeling and oocyte transcription, which is related to increased oocyte developmental competence \[[@r49]\]. We also showed that prolonged gap junctional communication between oocytes and cumulus cells alters oocyte metabolites, such as nicotinamide adenine dinucleotide and oxidized flavin adenine dinucleotide, which may be the result of EGF-like peptide stimulation in cumulus cells \[[@r7]\]. Pre-IVM culture with forskolin and IBMX significantly increased oocyte mitochondrial membrane potential and ATP content in mice \[[@r33]\], and increased bovine intra-oocyte glutathione levels in a GJC-dependent manner, enabling the oocyte to be more able to resist oxidative stress \[[@r34]\]. A further important consequence of possessing a fully developed EGF-like peptide-EGFR signaling cascade in the COC is translation of stored maternal mRNA transcripts during oocyte maturation, that may be important for oocyte developmental competence \[[@r50]\]. Hence, improved oocyte maturation conditions may facilitate the efficient transport of EGF-like peptide-stimulated metabolites and molecules from cumulus cells into oocytes via gap junctions, and as a result, lead to improved metabolic and translation states in the oocyte.

In conclusion, the present study hypothesized that effective pre-maturation *in vitro* with dbcAMP and IBMX could potentially mimic *in vivo* FSH-priming of animals, which is an effective but nonetheless inefficient means of enhancing oocyte developmental competence and IVM outcomes. Pre-maturation with cAMP modulators seems to be important for priming the oocyte for final oocyte maturation, which involves facilitating cell-to-cell gap junctional communication and functional EGFR signaling, required for developmental competence of bovine oocytes *in vitro*. This knowledge has significant implications for improving the developmental competence of oocytes derived from small antral follicles of FSH-unprimed animals.
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